Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Exp Clin Cancer Res ; 25(4): 575-83, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17310849

ABSTRACT

Nucleostemin (NS) is preferentially and exclusively expressed in the stem cells and cancer cells, but not in differentiated adult tissues and cells. NS is likely to take part in controlling the proliferation and differentiation switch in stem cells and progenitor cells. Its deregulation in cancer also contributes to the elevated proliferation and undifferentiation of cancer cells. However, the mechanisms by which NS helps to maintain both cancer and stem cells in undifferentiated state remain unclear. In this study, we carried out gene profilings using oligonucleotide DNA microarray after knocking down the expression of NS in Hela cells. Of the 21,329 genes, 200 genes were found differentially expressed in NS silenced Hela cells with > 2 fold ratio (either > 2 or < 0.5). Category analysis indicated these differential genes were mainly related with cancer pathogenesis, cell death, cell growth and proliferation. NS related gene pathway analysis suggested NS was mostly involved in the networks of cell cycle and differentiation controls. p53 may not be the only partner of NS in its regulated pathways. c-Myc may directly or indirectly interact with it to control the proliferation and differentiation switch in cancer cells. Our study provides a general view of the NS-target genes, and indicates the possible pathways in which NS plays its role in proliferation control.


Subject(s)
Carrier Proteins/genetics , Gene Expression Profiling , Nuclear Proteins/genetics , Oligonucleotide Array Sequence Analysis , GTP-Binding Proteins , Gene Expression Regulation, Neoplastic , HeLa Cells , Humans , Nucleic Acid Hybridization , Oligodeoxyribonucleotides , RNA, Small Interfering/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...